Eduardo Bruno Martins
CIK 1670431 · Chief Medical Officer · last filed 2026-02-20
Eduardo Bruno Martins is a Chief Medical Officer who has filed 10 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing, for SGMT, was dated Feb 20, 2026. Across all open-market trades the lifetime net is −$121.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $954.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$954.5K
2
10
-$121.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SGMT | Chief Medical Officer | 147,296 | $6.48 | $954.5K | -$121.0K | 7 | 2026-02-20 |
| Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | SVP, Liver and Infectious Dise | — | $1.73 | — | $0 | 3 | 2017-03-14 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-20 | SGMT | Grant (A) | +44,000 | $0 | EDGAR |
| 2026-02-12 | SGMT | Sell (S) | −3,640 | -$19.5K | EDGAR |
| 2025-07-23 | SGMT | Sell (S) | −8,277 | -$75.6K | EDGAR |
| 2025-02-07 | SGMT | Grant (A) | +34,000 | $0 | EDGAR |
| 2024-07-23 | SGMT | Sell (S) | −8,357 | -$25.9K | EDGAR |
| 2023-11-21 | SGMT | Grant (A) | +89,570 | $0 | EDGAR |
| 2023-07-20 | SGMT | Mixed | — | $0 | EDGAR |
| 2017-03-14 | Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-09-15 | Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-03-28 | Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Grant (A) | — | $0 | EDGAR |